Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Second biosimilar of Remicade approved in the US, but J&J not rattled
BioPharma Dive
Mon, 04/24/17 - 10:02 pm
Tags:
Remicade, JNJ, biosimilars, Renflexis, Merck, Samsung Bioepis
Prescribed Reading: What J&J says about the rest of pharma
BioPharma Dive
Sun, 04/23/17 - 09:53 am
Tags:
JNJ, earnings
3 Things Johnson & Johnson Didn't Tell You in Its Q1 Earnings Update
Motley Fool
Sat, 04/22/17 - 01:04 pm
Tags:
JNJ, earnings
The Latest on J&J’s Device Strategy
Qmed
Thu, 04/20/17 - 09:46 am
Tags:
JNJ, devices
Pharma bellwether J&J not worried about drug pricing for specialty meds
BioPharma Dive
Wed, 04/19/17 - 10:01 am
Tags:
JNJ, drug pricing, earnings
Will Biotechs Feel Johnson & Johnson's Pain?
Barron's
Tue, 04/18/17 - 09:07 pm
Tags:
biotech, JNJ, earnings
J&J's Remicade sees 'very little' biosim erosion, but payers are sticking it to Xarelto
Fierce Pharma
Tue, 04/18/17 - 09:03 pm
Tags:
JNJ, Remicade, biosimilars, payers, Xarelto, Inflectra
Johnson & Johnson: Help Me Actelion, You're My Only Hope
Barron's
Tue, 04/18/17 - 09:01 pm
Tags:
JNJ, Actelion, M&A, earnings
Johnson & Johnson tops 1Q profit forecasts, but net dips
Yahoo/AP
Tue, 04/18/17 - 09:54 am
Tags:
JNJ, earnings
Immunology Among Areas to Watch as Johnson & Johnson Gears Up to Report Results
TheStreet.com
Mon, 04/17/17 - 10:59 pm
Tags:
JNJ, earnings, immunology, diabetes
Will Johnson & Johnson Earnings Send the Stock to New Highs?
Motley Fool
Mon, 04/17/17 - 11:09 am
Tags:
JNJ, earnings
Johnson & Johnson’s Consumer Segment: What to Expect in 1Q17
Market Realist
Fri, 04/14/17 - 10:06 am
Tags:
JNJ, consumer health
Johnson & Johnson’s Revenue Estimates: Expect Growth!
Market Realist
Thu, 04/13/17 - 06:40 pm
Tags:
JNJ, earnings
About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet
Fierce Pharma
Mon, 04/10/17 - 10:19 am
Tags:
M&A, Stada, Shire, Baxalta, JNJ, Actelion, Mylan Labs, Pfizer, Takeda, Ariad Pharmaceuticals, Medivation
Google still scrambling for solutions after J&J, others depart YouTube advertising
Fierce Pharma
Mon, 04/10/17 - 10:08 am
Tags:
JNJ, YouTube, drug ads, DTC advertising
J&J-sponsored documentary underscores global pandemic threats
Fierce Pharma
Sun, 04/9/17 - 12:28 pm
Tags:
JNJ, pandemic
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
Tags:
JNJ, Actelion, Darzalex, Novartis, Cosentyx, Jakavi, Lucentis, Tasigna, Roche, Venclexta, Tecentriq, emicizumab
Actelion shareholders OK R&D spinout
Drug Delivery Business News
Wed, 04/5/17 - 12:04 pm
Tags:
Actelion, R&D, spinoffs, JNJ
Looking for Darzalex sales expansion, J&J, Genmab hit a wall in lymphoma
Fierce Pharma
Tue, 04/4/17 - 07:29 pm
Tags:
Darzalex, JNJ, Genmab, non-Hodgkin's lymphoma
Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much
Fierce Pharma
Sat, 04/1/17 - 08:14 am
Tags:
JNJ, Pfizer, Merck, AbbVie, Eli Lilly, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.